276 related articles for article (PubMed ID: 23602401)
1. Novel adenosine A(2A) receptor ligands: a synthetic, functional and computational investigation of selected literature adenosine A(2A) receptor antagonists for extending into extracellular space.
Jörg M; Shonberg J; Mak FS; Miller ND; Yuriev E; Scammells PJ; Capuano B
Bioorg Med Chem Lett; 2013 Jun; 23(11):3427-33. PubMed ID: 23602401
[TBL] [Abstract][Full Text] [Related]
2. Revisiting a receptor-based pharmacophore hypothesis for human A(2A) adenosine receptor antagonists.
Bacilieri M; Ciancetta A; Paoletta S; Federico S; Cosconati S; Cacciari B; Taliani S; Da Settimo F; Novellino E; Klotz KN; Spalluto G; Moro S
J Chem Inf Model; 2013 Jul; 53(7):1620-37. PubMed ID: 23705857
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and SAR studies of analogues of 4-(3,3-dimethyl-butyrylamino)-3,5-difluoro-N-thiazol-2-yl-benzamide (Lu AA41063) as adenosine A2A receptor ligands with improved aqueous solubility.
Mikkelsen GK; Langgård M; Schrøder TJ; Kreilgaard M; Jørgensen EB; Brandt G; Griffon Y; Boffey R; Bang-Andersen B
Bioorg Med Chem Lett; 2015 Mar; 25(6):1212-6. PubMed ID: 25701253
[TBL] [Abstract][Full Text] [Related]
4. Discovery of aminoquinazoline derivatives as human A(2A) adenosine receptor antagonists.
Zhou G; Aslanian R; Gallo G; Khan T; Kuang R; Purakkattle B; De Ruiz M; Stamford A; Ting P; Wu H; Wang H; Xiao D; Yu T; Zhang Y; Mullins D; Hodgson R
Bioorg Med Chem Lett; 2016 Feb; 26(4):1348-54. PubMed ID: 26781932
[TBL] [Abstract][Full Text] [Related]
5. Crystal structure of the adenosine A
Sun B; Bachhawat P; Chu ML; Wood M; Ceska T; Sands ZA; Mercier J; Lebon F; Kobilka TS; Kobilka BK
Proc Natl Acad Sci U S A; 2017 Feb; 114(8):2066-2071. PubMed ID: 28167788
[TBL] [Abstract][Full Text] [Related]
6. Molecular Basis of Ligand Dissociation from the Adenosine A2A Receptor.
Guo D; Pan AC; Dror RO; Mocking T; Liu R; Heitman LH; Shaw DE; IJzerman AP
Mol Pharmacol; 2016 May; 89(5):485-91. PubMed ID: 26873858
[TBL] [Abstract][Full Text] [Related]
7. Complementarity between in silico and biophysical screening approaches in fragment-based lead discovery against the A(2A) adenosine receptor.
Chen D; Ranganathan A; IJzerman AP; Siegal G; Carlsson J
J Chem Inf Model; 2013 Oct; 53(10):2701-14. PubMed ID: 23971943
[TBL] [Abstract][Full Text] [Related]
8. Substructure-based virtual screening for adenosine A2A receptor ligands.
van der Horst E; van der Pijl R; Mulder-Krieger T; Bender A; Ijzerman AP
ChemMedChem; 2011 Dec; 6(12):2302-11. PubMed ID: 22021213
[TBL] [Abstract][Full Text] [Related]
9. Selecting an optimal number of binding site waters to improve virtual screening enrichments against the adenosine A2A receptor.
Lenselink EB; Beuming T; Sherman W; van Vlijmen HW; IJzerman AP
J Chem Inf Model; 2014 Jun; 54(6):1737-46. PubMed ID: 24835542
[TBL] [Abstract][Full Text] [Related]
10. Potent and selective adenosine A(2A) receptor antagonists: [1,2,4]-triazolo[4,3-c]pyrimidin-3-ones.
Harris JM; Neustadt BR; Zhang H; Lachowicz J; Cohen-Williams M; Varty G; Hao J; Stamford AW
Bioorg Med Chem Lett; 2011 Apr; 21(8):2497-501. PubMed ID: 21398125
[TBL] [Abstract][Full Text] [Related]
11. Carbamate substituted 2-amino-4,6-diphenylpyrimidines as adenosine receptor antagonists.
Robinson SJ; Petzer JP; Rousseau AL; Terre'Blanche G; Petzer A; Lourens ACU
Bioorg Med Chem Lett; 2016 Feb; 26(3):734-738. PubMed ID: 26776359
[TBL] [Abstract][Full Text] [Related]
12. Design and synthesis of (4E)-4-(4-substitutedbenzylideneamino)-3-substituted-2,3-dihydro-2-thioxothiazole-5-carbonitrile as novel A2A receptor antagonists.
Mishra CB; Sharma D; Prakash A; Kumari N; Kumar N; Luthra PM
Bioorg Med Chem; 2013 Oct; 21(19):6077-83. PubMed ID: 23953686
[TBL] [Abstract][Full Text] [Related]
13. An Fc-Small Molecule Conjugate for Targeted Inhibition of the Adenosine 2A Receptor.
Hsiao PY; Kalin JH; Sun IH; Amin MN; Lo YC; Chiang MJ; Giddens J; Sysa-Shah P; Gabrielson K; Wang LX; Powell JD; Cole PA
Chembiochem; 2016 Oct; 17(20):1951-1960. PubMed ID: 27432157
[TBL] [Abstract][Full Text] [Related]
14. Binding kinetics of ZM241385 derivatives at the human adenosine A2A receptor.
Guo D; Xia L; van Veldhoven JP; Hazeu M; Mocking T; Brussee J; Ijzerman AP; Heitman LH
ChemMedChem; 2014 Apr; 9(4):752-61. PubMed ID: 24591302
[TBL] [Abstract][Full Text] [Related]
15. Discovery of novel 1,3,5-triazine as adenosine A
Masih A; Agnihotri AK; Srivastava JK; Pandey N; Bhat HR; Singh UP
J Biochem Mol Toxicol; 2021 Mar; 35(3):e22659. PubMed ID: 33156955
[TBL] [Abstract][Full Text] [Related]
16. New 8-amino-1,2,4-triazolo[4,3-a]pyrazin-3-one derivatives. Evaluation of different moieties on the 6-aryl ring to obtain potent and selective human A
Falsini M; Ceni C; Catarzi D; Varano F; Dal Ben D; Marucci G; Buccioni M; Martí Navia A; Volpini R; Colotta V
Bioorg Med Chem Lett; 2020 Jun; 30(11):127126. PubMed ID: 32241719
[TBL] [Abstract][Full Text] [Related]
17. Bridging molecular docking to membrane molecular dynamics to investigate GPCR-ligand recognition: the human A₂A adenosine receptor as a key study.
Sabbadin D; Ciancetta A; Moro S
J Chem Inf Model; 2014 Jan; 54(1):169-83. PubMed ID: 24359090
[TBL] [Abstract][Full Text] [Related]
18. 2-Aminopyrimidines as dual adenosine A1/A2A antagonists.
Robinson SJ; Petzer JP; Terre'Blanche G; Petzer A; van der Walt MM; Bergh JJ; Lourens AC
Eur J Med Chem; 2015 Nov; 104():177-88. PubMed ID: 26462195
[TBL] [Abstract][Full Text] [Related]
19. Identification of novel adenosine A(2A) receptor antagonists by virtual screening.
Langmead CJ; Andrews SP; Congreve M; Errey JC; Hurrell E; Marshall FH; Mason JS; Richardson CM; Robertson N; Zhukov A; Weir M
J Med Chem; 2012 Mar; 55(5):1904-9. PubMed ID: 22250781
[TBL] [Abstract][Full Text] [Related]
20. The adenosine A(2A) antagonistic properties of selected C8-substituted xanthines.
Van der Walt MM; Terre'Blanche G; Petzer A; Lourens AC; Petzer JP
Bioorg Chem; 2013 Aug; 49():49-58. PubMed ID: 23892098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]